Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
NAMSW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.22
N/A
NA
vs NA
Q4.22
N/A
NA
vs NA
Q1.23
N/A
NA
vs NA
Q2.23
N/A
NA
vs NA
Q3.23
N/A
NA
vs NA
Q4.23
N/A
NA
vs NA
Q1.24
N/A
NA
vs NA
Q2.24
N/A
NA
vs NA
Q3.24
N/A
NA
vs NA
Q4.24
N/A
NA
vs NA
Sales Growth
YoY
Current
Estimates
Q4.22
NA
1.4M vs NA
Q1.23
-83%
8M vs 46.8M
Q2.23
-97%
1.6M vs 46.8M
Q3.23
-67%
1.9M vs 5.6M
Q4.23
+15%
1.6M vs 1.4M
Q1.24
-84%
1.3M vs 8M
Q2.24
+35%
2.1M vs 1.6M
Q3.24
+1451%
29.1M vs 1.9M
Q4.24
+701%
12.8M vs 1.6M
Q1.25
+2%
1.3M vs 1.3M
Return on Equity
QoQ
Q2.23
NA
NA
vs -0.08
Q2.23
-8%
-0.08
vs NA
Q3.23
NA
NA
vs -0.08
Q4.23
-16%
-0.16
vs NA
Q1.24
-24%
-0.24
vs -0.16
Q2.24
-10%
-0.10
vs -0.24
Q3.24
-4%
-0.04
vs -0.10
Q4.24
-12%
-0.12
vs -0.04
Institutionnal Ownership
Forecast
21%2025-Revenue
100%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases. Its lead investigational candidate, obicetrapib, is a novel, selective inhibitor that targets the Cholesteryl Ester Transfer Protein (CETP), which has been clinically shown to reduce low-density lipoprotein cholesterol (LDL-C) while at the same time substantially increase high-density lipoprotein cholesterol (HDL-C). The company was founded in 2019 and is based in Naarden, the Netherlands.
NASDAQ
Relative Strenght
17
Volume Buzz
-96%
Earning Acce
No
Dist 52w H.
52%Relative Strength
NAMSW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How NAMSW compares to sector?